. Author manuscript; available in PMC: 2018 Aug 1.

Published in final edited form as: Liver Int. 2017 Mar 7;37(8):1177–1183. doi: 10.1111/liv.13379

Table 4.

Refining Baveno criteria

	A U.S. cohort (n=161) – 9% HRV				B Italian Cohort (n=101) – 17% HRV
	EGDs avoided	HRV	Sensitivity	NPV	EGDs avoided	HRV	Sensitivity	NPV
Baveno criteria	41 (26%)	0/14	100% (77-100)	100% (91-100)	16 (16%)	0/17	100% (80-100)	100% (79-100)
PLT >150	73 (45%)	0/14	100% (77-100)	100% (95-100)	19 (19%)	1^*/17 (1%)	94% (71-100)	95% (75-100)
MELD =6	29 (19%)	0/14	100% (77-100)	100% (88-100)	16 (16%)	0/17	100% (80-100)	100% (79-100)
Baveno/MELD=6	60 (38%)	0/14	100% (77-100)	100% (94-100)	28 (28%)	0/17	100% (80-100)	100% (88-100)
PLT >150/MELD=6	86 (54%)	0/14	100% (77-100)	100% (96-100)	30 (30%)	1^*/17 (1%)	94% (71-100)	97% (83-100)

HRV= High risk varices; EGD= esophagogastroduodenoscopy; PLT= platelet count (×1000/mm3); Baveno/MELD adds patients who do not fulfill Baveno criteria (PLT<150 and LSM >20) but have a MELD <7; PLT/MELD adds patients with a platelet count <150,000 but have a MELD =6

patient with PLT 340, LSM 22.5 and medium-sized varices